Table 1.
Treatment | Hippocampus | Cortex | ||
---|---|---|---|---|
Control | N-Aβcore | Control | N-Aβcore | |
Microglia: Iba1High CD68High | ||||
1.5 mo vs 7 mo B6SJL | p < 0.0001 | p < 0.0001 | p = 0.0002 | p = 0.0016 |
1.5 mo vs 7 mo 5xFAD | p < 0.0001 | p < 0.0001 | p < 0.0001 | p < 0.0001 |
1.5 mo B6SJL Control vs N-Aβcore | p = 0.9996 | p = 0.7463 | ||
1.5 mo 5xFAD Control vs N-Aβcore | p = 0.4282 | p = 0.7463 | ||
7 mo B6SJL Control vs N-Aβcore | p = 0.0296 | p = 0.3023 | ||
7 mo 5xFAD Control vs N-Aβcore | p = 0.1138 | p = 0.4216 | ||
Astrocytes: GFAPHigh | ||||
1.5 mo vs 7 mo B6SJL | p = 0.9632 | p = 0.9996 | p = 0.0946 | p = 0.9997 |
1.5 mo vs 7 mo 5xFAD | p = 0.0003 | p = 0.0124 | p < 0.0001 | p = 0.0620 |
1.5 mo B6SJL Control vs N-Aβcore | p = 0.9513 | p = 0.9997 | ||
1.5 mo 5xFAD Control vs N-Aβcore | p = 0.9940 | p = 0.0339 | ||
7 mo B6SJL Control vs N-Aβcore | p = 0.3343 | p = 0.1082 | ||
7 mo 5xFAD Control vs N-Aβcore | p = 0.3853 | p < 0.0001 |
p values from Tukey post hoc tests of two-way ANOVAs of number of hippocampal and cortical cells positive for the phenotypic markers